Opinion
Video
Access Challenges Regarding the Use of Abiraterone in Patients With mCRPC
Panelists discuss how to address the challenges in providing optimal care for mCRPC patients and how barriers may vary between different healthcare settings, such as rural vs. urban and private vs. public.
EP: 1.Expert Perspective on the Expanding Treatment Landscape in mCRPC
EP: 2.The Role of Androgen Receptor-Targeted Therapy in the Treatment of mCRPC
EP: 3.Management of Comment Adverse Effects Associated with mCRPC Therapies
EP: 4.Treatment Sequencing With Androgen Receptor-Targeted Therapies for mCRPC
EP: 5.Overview of Abiraterone and the Differences Between Formulations
EP: 6.Combining Abiraterone with Steroids
EP: 7.The Importance of Serum Testosterone Levels With the Use of Androgen Receptor-Targeting Therapies
EP: 8.Clinical Attributes of Patients Who Would Benefit From Micronized Abiraterone
EP: 9.Dosing and Administration Considerations for Abiraterone Formulations
Now Viewing
EP: 10.Access Challenges Regarding the Use of Abiraterone in Patients With mCRPC
EP: 11.Future Directions in mCRPC
- mCRPC patients?
- How do you navigate these challenges to ensure patients receive optimal care?
- How might the barriers differ between various health care settings (eg, rural vs urban, private vs public)?
Related Videos
Related Content
